(HealthDay News) — About 20% of patients with diabetes hospitalized with COVID-19 die within 28 days and about 50% are discharged, and predictors of death and discharge have…
[mc4wp_form id="449"]
(HealthDay News) — Deceased organ donation increased among some racial groups, particularly among Black people, from 1999 to 2017, but substantial racial and ethnic differences remain, according to…
(HealthDay News) — For patients presenting with COVID-19, abnormal sodium levels are associated with mortality and needing ventilatory support, according to a study published online in the Journal…
(HealthDay News) — Veterans who receive all their post-kidney transplant care within the Veterans Health Administration have reduced mortality, according to a study published online in the Clinical…
(HealthDay News) — Users of terazosin, doxazosin, or alfuzosin are at lower risk for developing Parkinson disease (PD) compared with users of tamsulosin, according to a study published…
Venous thromboembolism (VTE) among patients with lupus nephritis (LN) is not limited to those with class 5 disease, but extends to those with class 3 or 4 disease,…
Certain groups of patients with nondialysis-dependent chronic kidney disease (CKD) require additional management to control their hemoglobin levels (Hb), according to investigators. In the national Swedish Renal Registry,…
(HealthDay News) — For first-line treatment of advanced renal cell carcinoma, progression-free and overall survival are significantly longer with lenvatinib plus pembrolizumab versus sunitinib, according to a study…
New study data indicate that VEGF inhibition suppressed angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system that has antitumor activity, in a mouse model of…
Heart failure risk is increased among men taking an alpha blocker (AB) or 5-alpha reductase inhibitor (5ARI) for benign prostatic hyperplasia (BPH), with greater risks among AB users,…